C130H235F2N43O — CID 157098164
4-(azetidin-1-ylmethyl)-1-tert-butylpyrazole;1-(2-tert-butyl-4-fluoro-1H-imidazol-5-yl)-N-methylmethanamine;1-(1-tert-butyl-3-fluoropyrazol-4-yl)-N-methylmethanamine;4-tert-butyl-1-methylimidazole;4-tert-butyl-1-methyltriazole;1-(5-tert-butyl-1,2-oxazol-3-yl)-N-methylmethanamine;1-(1-tert-butylpyrazol-4-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrazol-4-yl)methanamine;1-(1-tert-butylpyrazol-4-yl)-N-methylmethanamine;1-tert-butyl-4-[(2R)-pyrrolidin-2-yl]pyrazole;1-tert-butyl-4-[(2S)-pyrrolidin-2-yl]pyrazole;1-tert-butyl-4-[(2S)-pyrrolidin-2-yl]triazole;1-tert-butyl-4-[(2R)-pyrrolidin-2-yl]triazole;1-(1-tert-butyltriazol-4-yl)-N-methylmethanamine (PubChem CID 157098164) has the molecular formula C130H235F2N43O and a molecular weight of 2454.61 g/mol. Its IUPAC name is 4-(azetidin-1-ylmethyl)-1-tert-butylpyrazole;1-(2-tert-butyl-4-fluoro-1H-imidazol-5-yl)-N-methylmethanamine;1-(1-tert-butyl-3-fluoropyrazol-4-yl)-N-methylmethanamine;4-tert-butyl-1-methylimidazole;4-tert-butyl-1-methyltriazole;1-(5-tert-butyl-1,2-oxazol-3-yl)-N-methylmethanamine;1-(1-tert-butylpyrazol-4-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrazol-4-yl)methanamine;1-(1-tert-butylpyrazol-4-yl)-N-methylmethanamine;1-tert-butyl-4-[(2R)-pyrrolidin-2-yl]pyrazole;1-tert-butyl-4-[(2S)-pyrrolidin-2-yl]pyrazole;1-tert-butyl-4-[(2S)-pyrrolidin-2-yl]triazole;1-tert-butyl-4-[(2R)-pyrrolidin-2-yl]triazole;1-(1-tert-butyltriazol-4-yl)-N-methylmethanamine.
| Compound Name | 4-(azetidin-1-ylmethyl)-1-tert-butylpyrazole;1-(2-tert-butyl-4-fluoro-1H-imidazol-5-yl)-N-methylmethanamine;1-(1-tert-butyl-3-fluoropyrazol-4-yl)-N-methylmethanamine;4-tert-butyl-1-methylimidazole;4-tert-butyl-1-methyltriazole;1-(5-tert-butyl-1,2-oxazol-3-yl)-N-methylmethanamine;1-(1-tert-butylpyrazol-4-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrazol-4-yl)methanamine;1-(1-tert-butylpyrazol-4-yl)-N-methylmethanamine;1-tert-butyl-4-[(2R)-pyrrolidin-2-yl]pyrazole;1-tert-butyl-4-[(2S)-pyrrolidin-2-yl]pyrazole;1-tert-butyl-4-[(2S)-pyrrolidin-2-yl]triazole;1-tert-butyl-4-[(2R)-pyrrolidin-2-yl]triazole;1-(1-tert-butyltriazol-4-yl)-N-methylmethanamine |
|---|---|
| PubChem CID | 157098164 |
| Molecular Formula | C130H235F2N43O |
| Molecular Weight | 2454.61 g/mol |
| Exact Mass | 2452.96 |
| IUPAC Name | 4-(azetidin-1-ylmethyl)-1-tert-butylpyrazole;1-(2-tert-butyl-4-fluoro-1H-imidazol-5-yl)-N-methylmethanamine;1-(1-tert-butyl-3-fluoropyrazol-4-yl)-N-methylmethanamine;4-tert-butyl-1-methylimidazole;4-tert-butyl-1-methyltriazole;1-(5-tert-butyl-1,2-oxazol-3-yl)-N-methylmethanamine;1-(1-tert-butylpyrazol-4-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrazol-4-yl)methanamine;1-(1-tert-butylpyrazol-4-yl)-N-methylmethanamine;1-tert-butyl-4-[(2R)-pyrrolidin-2-yl]pyrazole;1-tert-butyl-4-[(2S)-pyrrolidin-2-yl]pyrazole;1-tert-butyl-4-[(2S)-pyrrolidin-2-yl]triazole;1-tert-butyl-4-[(2R)-pyrrolidin-2-yl]triazole;1-(1-tert-butyltriazol-4-yl)-N-methylmethanamine |
| SMILES | CC(C)(C)n1cc(CN)cn1.CC(C)(C)n1cc(CN2CCC2)cn1.CC(C)(C)n1cc([C@@H]2CCCN2)cn1.CC(C)(C)n1cc([C@@H]2CCCN2)nn1.CC(C)(C)n1cc([C@H]2CCCN2)cn1.CC(C)(C)n1cc([C@H]2CCCN2)nn1.CN(C)Cc1cnn(C(C)(C)C)c1.CNCc1[nH]c(C(C)(C)C)nc1F.CNCc1cc(C(C)(C)C)on1.CNCc1cn(C(C)(C)C)nc1F.CNCc1cn(C(C)(C)C)nn1.CNCc1cnn(C(C)(C)C)c1.Cn1cc(C(C)(C)C)nn1.Cn1cnc(C(C)(C)C)c1 |
| InChI | InChI=1S/3C11H19N3.2C10H18N4.C10H19N3.2C9H16FN3.C9H17N3.C9H16N2O.C8H16N4.C8H15N3.C8H14N2.C7H13N3/c1-11(2,3)14-9-10(7-12-14)8-13-5-4-6-13;2*1-11(2,3)14-8-9(7-13-14)10-5-4-6-12-10;2*1-10(2,3)14-7-9(12-13-14)8-5-4-6-11-8;1-10(2,3)13-8-9(6-11-13)7-12(4)5;1-9(2,3)13-6-7(5-11-4)8(10)12-13;1-9(2,3)8-12-6(5-11-4)7(10)13-8;1-9(2,3)12-7-8(5-10-4)6-11-12;1-9(2,3)8-5-7(6-10-4)11-12-8;1-8(2,3)12-6-7(5-9-4)10-11-12;1-8(2,3)11-6-7(4-9)5-10-11;1-8(2,3)7-5-10(4)6-9-7;1-7(2,3)6-5-10(4)9-8-6/h7,9H,4-6,8H2,1-3H3;2*7-8,10,12H,4-6H2,1-3H3;2*7-8,11H,4-6H2,1-3H3;6,8H,7H2,1-5H3;6,11H,5H2,1-4H3;11H,5H2,1-4H3,(H,12,13);6-7,10H,5H2,1-4H3;5,10H,6H2,1-4H3;6,9H,5H2,1-4H3;5-6H,4,9H2,1-3H3;5-6H,1-4H3;5H,1-4H3/t;2*10-;2*8-;;;;;;;;;/m.1010........./s1 |
| InChIKey | AFLIEJSJPBICDC-ULTSPWCFSA-N |
| XLogP | 21.37 |
| TPSA | 460.88 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 43 |
| Rotatable Bonds | 19 |
| Heavy Atoms | 176 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2454.61 |
| LogP ≤ 5 | 21.37 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 43 |